EW
Edwards Lifesciences Corp
86.30$
+0.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 33.1% | 10.8% | -4.0% | 26.8% | 26.0% | 20.2% | 19.8% | 18.9% | 36.9% | 28.7% | 2.7% | 37.4% | 26.4% | |
| 3.0% | 2.9% | 2.9% | 2.9% | 2.5% | 2.6% | 2.6% | 2.5% | 2.5% | 2.7% | 2.5% | 2.5% | 2.5% | |
| 2.6% | 2.4% | 3.4% | 3.2% | 3.1% | 2.9% | 2.8% | 2.4% | 2.7% | 2.5% | 2.8% | 2.4% | 2.6% | |
| 0.2% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -1.0% | -17.1% | -34.5% | -1.5% | 50.5% | -10.9% | -10.7% | -9.2% | 5.4% | 16.2% | -30.4% | 7.6% | -0.5% | |
| 4.4% | 8.0% | 6.4% | 6.2% | 2.4% | 4.0% | 4.0% | 3.2% | 3.7% | 6.2% | 3.9% | 3.8% | 4.4% | |
| 7.2% | 1.1% | 4.7% | 9.0% | 199.5% | 6.2% | 6.0% | -11.2% | -27.5% | -12.6% | -5.6% | -11.1% | -14.0% | |
| – | 2.6% | – | – | – | – | – | – | – | – | – | – | – | |
| -14.0% | -35.4% | 0.0% | -11.4% | -66.5% | -18.7% | -14.8% | -0.4% | 10.1% | -2.6% | -31.7% | -3.1% | -7.0% | |
| -11.5% | -32.6% | 4.6% | -7.0% | -72.1% | -18.6% | -18.3% | 3.4% | -47.7% | -0.7% | -27.4% | 0.0% | -18.5% | |
| 29.5% | -21.0% | 6.1% | 31.0% | 150.3% | 6.5% | 6.4% | 9.2% | -38.3% | 15.6% | -29.8% | 26.5% | -5.8% | |
| 28.6% | 2.8% | -10.4% | 20.6% | 23.6% | 16.2% | 15.9% | 15.7% | 33.2% | 22.5% | -1.3% | 33.6% | 22.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.